Latest News

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

KandenkoLtd's (TSE:1942) stock is up by a considerable 20% over the past three months. Since the market usually pay for...

By buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...

MoonLake Immunotherapeutics (MLTX) is back in the spotlight after disclosing that lead drug candidate sonelokimab fell short of a rival treatment in Phase 3 trials, triggering lawsuits and a brutal repricing of the stock. See our latest analysis for MoonLake Immunotherapeutics. The latest bounce to a share price of $14.79, reflected in a 1 month share price return of 15.82 percent, comes after a brutal 90 day share price collapse of 72.24 percent and a 1 year total shareholder return of...

In recent weeks, Waste Management has seen improving sentiment as analysts raised earnings estimates and projected year-over-year growth ahead of its upcoming results. Behind this optimism lies a view that the company’s near-term business health and profitability could strengthen, even as it contends with rising capital needs and margin pressures. We’ll now examine how this analyst optimism ahead of earnings might influence Waste Management’s investment narrative built around...

MMG Limited recently reshaped its leadership structure, appointing Cao Liang as chairman, naming new presidents for Las Bambas and Africa operations, elevating Nan Wang to Chief Operating Officer, and expanding Chief Financial Officer Qian Song’s responsibilities as of early December 2025. This leadership refresh concentrates experienced operators and project managers in MMG’s most important assets, potentially influencing how the group executes growth plans and manages operational and...

Earlier this month, Exponent, Inc. reported third-quarter revenues that grew 9.6% year on year and exceeded analyst expectations by 4%, crediting its diversified portfolio and broad industry reach. This performance marked the strongest analyst estimates beat among its peer group, underlining how Exponent’s cross-sector expertise is translating into resilient demand. Next, we’ll examine how Exponent’s double-digit net revenue growth and broad-based demand may influence its existing investment...

Citigroup Downgrade Puts Fresh Scrutiny on Seadrill Citigroup's move to cut Seadrill (NYSE:SDRL) from Buy to Neutral, while trimming its outlook, has put fresh attention on a stock already down about 19% this year, despite improving fundamentals. See our latest analysis for Seadrill. The downgrade lands after a choppy run for Seadrill, with a roughly 5.6% 1 month share price return failing to offset a near 19% year to date share price decline. The 3 year total shareholder return remains...

Renewed analyst optimism around Allot (ALLT), highlighted by its Zacks Rank of #1 Strong Buy and a sharply upgraded earnings outlook over the past 3 months, has pushed the stock sharply ahead of its tech peers. See our latest analysis for Allot. The optimism seems to be feeding directly into the tape, with Allot’s share price at $9.86 after a robust year to date share price return of around 59 percent and a standout 1 year total shareholder return of roughly 87 percent. This suggests momentum...

Recently, analysts upgraded NNN REIT on the back of its resilient triple-net retail portfolio, expectations for occupancy above 98% by year-end, and record-paced acquisition plans supported by about US$1.40 billion in liquidity and a BBB+ credit rating. An interesting angle is how NNN REIT’s rapid tenant turnarounds and consistent dividend growth record are reinforcing confidence in its ability to manage retail-sector risks while expanding its portfolio. We’ll now explore how this improved...

Bureau Veritas (ENXTPA:BVI) has slipped about 8% over the past month, extending its year-to-date decline. This naturally raises the question: has the market now overshot to the downside on this testing and certification specialist? See our latest analysis for Bureau Veritas. With the share price now around €25.88 after an 11% year to date share price decline, short term momentum is clearly fading, even though the three and five year total shareholder returns remain comfortably positive. If...

Global Atomic (TSX:GLO) just set up a CAD 350 million omnibus shelf registration, giving it wide latitude to issue common shares, warrants, units, or debt when it sees the right opportunity. See our latest analysis for Global Atomic. The move comes after a volatile stretch for Global Atomic, where a 26.0% 1 month share price return and a sharp 23.5% jump in the last session contrast with a much weaker 1 year total shareholder return. This suggests momentum is only just starting to rebuild. If...

Earlier this month, Instacart announced it became the first grocery partner to launch an end-to-end shopping app on ChatGPT and separately expanded its same-day delivery offering through a new partnership with The Home Depot Canada across more than 175 stores. Together, these moves highlight how Instacart is using AI-driven customer experiences and broader retailer coverage, including big and bulky items, to deepen its role in everyday household and home improvement purchasing. We’ll now...

CGI (TSX:GIB.A) just secured a new contract with the Texas Department of Information Resources, giving public agencies streamlined access to its government focused SaaS tools and services. For investors, this quietly strengthens CGI's U.S. public sector pipeline. See our latest analysis for CGI. The Texas win caps a busy stretch of U.S. public sector deals and cloud milestones. Yet CGI's year to date share price return of around minus 21% and one year total shareholder return of roughly minus...

With a price-to-earnings (or "P/E") ratio of 36.3x The a2 Milk Company Limited ( NZSE:ATM ) may be sending very bearish...

Key Insights The considerable ownership by retail investors in Isuzu Motors indicates that they collectively have a...

CHEMTRONICS.Co.,Ltd.'s ( KOSDAQ:089010 ) investors are due to receive a payment of ₩200.00 per share on 18th of April...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Indian Oil...

Key Insights The considerable ownership by private equity firms in Mapletree Pan Asia Commercial Trust indicates that...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...

Forvia (ENXTPA:FRVIA) just moved to redeem €200 million of its €700 million 3.75% 2028 notes, a proactive debt trim that can lighten future interest costs and subtly reshape the balance sheet. See our latest analysis for Forvia. The redemption move comes after Forvia began a strategic review and potential sale of parts of its interiors business. The market has taken notice, with a roughly 52% year to date share price return, but a still muted 3 year total shareholder return suggests that...

Token Corporation ( TSE:1766 ) has announced that it will be increasing its dividend from last year's comparable...

Innovent Biologics recently reported that its Phase 1b trial of mazdutide, a GLP-1/GCG dual agonist, in Chinese adolescents with obesity met its primary endpoint, showing meaningful weight-loss and metabolic improvements with a favorable safety profile. This is particularly significant because China currently has no approved weight-loss drugs for children or adolescents, positioning mazdutide as a potential first-in-class option in a rapidly growing and clinically underserved...

AutoZone, Inc. has reported past first-quarter 2025 results, with sales rising to US$4,628.63 million while net income and earnings per share declined year over year. The combination of higher revenue but lower profitability, alongside management’s commitment to opening more locations, highlights both growth ambition and cost pressures. We’ll now examine how AutoZone’s higher sales but softer earnings shape its investment narrative and the outlook for continued store expansion. Rare earth...